Stereochemistry | ACHIRAL |
Molecular Formula | C10H12N2O8.2Co |
Molecular Weight | 406.0773 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Co++].[Co++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
InChI
InChIKey=TWAWHTJKASJPEK-UHFFFAOYSA-J
InChI=1S/C10H16N2O8.2Co/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;/q;2*+2/p-4
Molecular Formula | C10H12N2O8 |
Molecular Weight | 288.2109 |
Charge | -4 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Co |
Molecular Weight | 58.933195 |
Charge | 2 |
Count |
MOL RATIO
2 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Dicobalt edetate was developed as a cyanide antidote based on the known ability of cobalt to form stable complexes with cyanide. One current cobalt-based antidote available in Europe is dicobalt-EDTA, sold as Kelocyanor. This agent chelates cyanide as the cobalticyanide. This drug provides an antidote effect more quickly than formation of methemoglobin. It can be very toxic and cause seizures, upper airway oedema, chest pain, hypotension, vomiting, rashes and dyspnoea especially in those who have not be exposed to cyanide.
CNS Activity
Originator
Approval Year
Sourcing
PubMed
Patents
Sample Use Guides
Rabbits: Rabbits receiving 50 mg/Kg of elemental cobalt
intravenously, given as cobalt disodium ethylenediamine
tetra-acetate (Cobalt Disodium Edetate), showed no detectable toxic
symptoms. Approximately 100 mg/Kg elemental cobalt, administered as rapidly
as possible, still produced no toxic symptoms except
for a questionable increase in respiratory rate.
Route of Administration:
Intravenous